Search Results - "Mok, Chiu Hang"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis by Cheung, Ka-Shing, Mok, Chiu-Hang, Lam, Lok-Ka, Mao, Xian-Hua, Mak, Lung-Yi, Seto, Wai-Kay, Yuen, Man-Fung

    “…We aimed to perform a network meta-analysis (NWM) to examine comparative effectiveness of non-selective beta blockers (NSBBs) on prophylaxis of…”
    Get full text
    Journal Article
  2. 2

    Correspondence on Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis" by Cheung, Ka Shing, Mok, Chiu Hang, Seto, Wai Kay, Yuen, Man Fung

    Published in Clinical and molecular hepatology (01-01-2023)
    “…[...]we could not perform subgroup analysis with respect to each comorbidity. Global percentage of asymptomatic SARS-CoV-2 infections among the tested…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis by Cheung, Ka Shing, Mok, Chiu Hang, Mao, Xianhua, Zhang, Ruiqi, Hung, Ivan Fn, Seto, Wai Kay, Yuen, Man Fung

    Published in Clinical and molecular hepatology (01-10-2022)
    “…Data of coronavirus disease 2019 (COVID-19) vaccine immunogenicity among chronic liver disease (CLD) and liver transplant (LT) patients are conflicting. We…”
    Get full text
    Journal Article
  6. 6

    Health State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia: A Systematic Review and Meta-Analysis by Mok, Chiu Hang, Kwok, Harley H.Y., Ng, Carmen S., Leung, Gabriel M., Quan, Jianchao

    Published in Value in health (01-07-2021)
    “…East and Southeast Asia has the greatest burden of diabetes in the world. We sought to derive a reference set of utility values for type 2 diabetes without…”
    Get full text
    Journal Article